Objective: Although intentional and unintentional rodenticide poisoning is
common, most readily, available agents are of relatively, low acute toxicit
y. A four-year long epidemic of severe toxicity from rodenticide exposure c
ontinues among patients predominantly, of Dominican descent living in New Y
ork City. This study, characterizes the ongoing epidemic of acute cholinest
erase inhibitor poisoning due to an illicit rodenticide and identifies its
etiology. Methods: A prospectively, collected case series of poisoned patie
nts referred to the New York City Poison Control Center. The main outcome m
easures include the clinical characteristics upon presentation, antidotal a
nd other therapeutic requirements, and patient outcome. Product analysis wa
s performed with paper chromatography, gas chromatography/mass spectrometry
, and high-performance liquid chromatography. A murine model assessing both
clinical effect and cholinesterase activity, was also performed. Results:
Thirty-five patients were referred following exposure to Tres Pasitos. Pati
ents developed signs of cholinergic hyperactivity and many, required high d
oses of atropine (> 10 mg) to control these symptoms. The source was identi
fied as a rodenticidal compound sold illicitly in local groceries primarily
within the Dominican community. Murine cholinesterase activity fell signif
icantly following exposure to the rodenticide. High-performance liquid chro
matography identified aldicarb, an extremely potent carbamate-type cholines
terase inhibitor, not licensed for rodenticidal use in this country. Conclu
sion: Illicit sale of undocumented compounds poses a substantial public hea
lth threat. Despite several public health interventions, the epidemic conti
nues.